Aquestive Therapeutics, Inc.

GOLDMAN SACHS GROUP INC AQST

Report date

12/31/2025

Quarter

2025 Q4

Filed

3/25/2026

Shares

909,064

Value ($000)

5,873

Weight

0.0%

2019 Q4 - 2025 Q4 (21 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	3/25/2026	5,873	0.0%	909,064	12/31/2025
2025 Q3	11/14/2025	2,209	0.0%	395,150	9/30/2025
2025 Q2	8/14/2025	1,737	0.0%	524,685	6/30/2025
2025 Q1	6/27/2025	2,375	0.0%	818,849	3/31/2025
2024 Q4	2/11/2025	3,120	0.0%	876,537	12/31/2024
2024 Q3	11/14/2024	1,109	0.0%	222,687	9/30/2024
2024 Q2	8/13/2024	296	0.0%	114,009	6/30/2024
2024 Q1	5/15/2024	2,243	0.0%	526,422	3/31/2024
2023 Q4	5/14/2024	62	0.0%	30,499	12/31/2023
2023 Q2	5/14/2024	94	0.0%	57,149	6/30/2023
2022 Q3	5/14/2024	32	0.0%	27,704	9/30/2022
2022 Q2	5/14/2024	9	0.0%	14,159	6/30/2022
2022 Q1	5/16/2022	126	0.0%	48,312	3/31/2022
2021 Q4	2/17/2022	223	0.0%	57,307	12/31/2021
2021 Q3	1/20/2022	319	0.0%	73,165	9/30/2021
2021 Q2	8/13/2021	270	0.0%	68,030	6/30/2021
2021 Q1	5/17/2021	243	0.0%	46,826	3/31/2021
2020 Q4	2/12/2021	274	0.0%	51,167	12/31/2020
2020 Q3	11/13/2020	390	0.0%	80,327	9/30/2020
2020 Q2	8/12/2020	96	0.0%	19,851	6/30/2020
2019 Q4	2/14/2020	281	0.0%	48,336	12/31/2019